Gaps in US Psychedelic Policy and How to Close Them
This Viewpoint discusses how to fill policy gaps surrounding the use of psychedelics to treat mental health and substance use conditions, should they be approved by the US Food and Drug Administration.
Authors
- Matthew D. Eisenberg (ORCID: https://orcid.org/0000-0002-8395-1877)
- David B. Yaden (ORCID: https://orcid.org/0000-0002-9604-6227)
- Caleigh Propes (ORCID: https://orcid.org/0009-0002-3198-480X)
- Katherine Cheung (ORCID: https://orcid.org/0009-0003-3529-4109)
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Berman Institute of Bioethics (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1001/jamahealthforum.2025.4928
- Citations
- 1
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.31
Funders
- Johns Hopkins University
- National Institute of Nursing Research